期刊文献+

抗人黑色素瘤单链抗体基因的克隆和分泌型表达 被引量:1

Cloning and Expression of An Anti human Melanoma Single chain Fv Gene
在线阅读 下载PDF
导出
摘要 应用RT-PCR技术从分泌抗人黑色素瘤单克隆抗体的杂交瘤细胞HB8760中克隆了抗体轻、重链可变区基因,然后用(Gly4Ser)3连接肽基因将VH、VL连接成ScFv基因,并进行了序列测定.计算机分析表明VH,VL均符合小鼠抗体可变区的特征,为功能性重排的抗体可变区基因.VH、VL、linker拼接正确.ScFv基因全长729bp,其中VH基因长360bp,编码120个氨基酸,VL基因长324bp,编码108个氨基酸.在噬菌粒表达载体pCANTAB5E中表达了可溶性的ScFv蛋白,表达产物经流式细胞仪检测可特异地与黑色素瘤细胞结合,不与肝癌。 The VH and VL genes were amplified from a mouse anti human melanoma hybridoma cell line HB8760 by RT PCR.The heavy and light chain variable regions were connected by a flexible linker,(Gly 4Ser) 3.The genes were sequenced and comarped with those published in EMBL genbank.The results showed that the VH and VL genes were homologous with the published mouse antibody variable region gene sequences.The VH and VL genes were 360bp and 324bp respectively and both of them were capable of encoding 120 and 108 amino acids.The deduced amino acid sequences contained four FRs,three CDRs and two cysteine residues necessary for the maintenance of the antibody structure,indicating that they were functionally rearranged.The fusion gene was cloned into a phagemid vector pCANTAB 5E and expressed in E.coli .The results of SDS PAGE and Western blot demonstated that the IPTG induced bacteria expressed an extra band of 30 kD in comparison with the uninduced ones.Immunofluorescence assay showed that the expressed protein had the affinity to a human melanoma cell line LiBr,but not to a liver cancer cell line or a stomach cancer cell line.
出处 《中国生物化学与分子生物学报》 CAS CSCD 1999年第1期58-62,共5页 Chinese Journal of Biochemistry and Molecular Biology
关键词 单链抗体 基因克隆 基因表达 黑色素瘤 Single chain antibody,Gene cloning,Gene expression,Melanoma
  • 相关文献

参考文献2

共引文献3

同被引文献13

  • 1Kuan C T, Pastan I. Improved antitumor activity of a recombinant antiLewis(y) immunotoxin not requiring proteolytic activation. Proc Natl Acad Sci USA, 1996,93(3) :974 ~ 978.
  • 2Kalland T, Dohlsten M, Abrahmsen L, Hedlund G, Bjork P, Lando P A, Sundstedt A, Akerblom E, Lind P. Targeting of superantigens. Cell Biophys, 1993,22(1-3): 147 ~ 164.
  • 3Hansson J, Ohlsson L, Persson R, Andersson G, Ilback N G, Litton M J, Kalland T, Dohlsten M. Genetically engineered superantigens as tolerable antitumor agents. Proc Natl Acad Sci USA, 1997,94(6) :2489~ 2494.
  • 4Dohlsten M., Hedlmd G. , Akerblom E., Lando P A. , Kalland T.antibody-targeted superantigens: a different class of anti-tumor agents.Proc Natl Acad Sci USA ,1991 ,88 (20): 9287 ~ 9291.
  • 5Brinkmann U, Pai L H, FitzGerald D J, Willingham M, Pastan I. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc Natl Acad Sci USA,1991 ,88(19) :8616 ~ 8620.
  • 6Pai L H, Batra J K, FitzGerald D J, Willingham M C, Pastan I.Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of human breast cancer and the evaluation of B3-PE toxicity in monkeys.Cancer Res, 1992,52( 11 ): 3189 ~ 3193.
  • 7Rajagopal V, Pastan I, Kreitman R J. A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: comparison with its singlechain and disulfide-stabilized homologs. Protein Eng, 1997,10(12):1453~ 1459.
  • 8Reiter Y, Brinkmann U, Jung S H, Lee B, Kasprzyk P G, King C R,Pastan I. Improved binding and antitumor activity of a recombinant antierbB2 immunotoxin by disulfide stabilization of the Fv fragment. J Biol Chem, 1994,269(28): 18327 ~ 18331.
  • 9Bera T K, Onda M, Brinkmann U, Pastan I. A bivalent disulfidestabilized Fv with improved antigen binding to erbB2. J Mol Biol,1998,281(3) :475 ~ 483.
  • 10Jung S H, Pastan I, Lee B. Design of interchain disulfide bonds in the framework region of the Fy fragment of the monoclonal antibody B3.Proteins, 1994,19( 1 ): 35 ~ 47.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部